NTLA: Message Board for Intellia Therapeutics Inc. - InvestorVillage


Intellia Therapeutics Inc.

  NTLA website

NTLA   /  Message Board

 
BOARD

GROUPS
 





 
Loading...
 
 
--




Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
24 Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Des GN jerrykrause 0 3/23/2023 12:46:47 PM
23 Intellia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Appli GN jerrykrause 1 3/4/2023 12:48:56 PM
22 Intellia Therapeutics Highlights Strategic Priorities and Anticipated 2023 Key Milest GN jerrykrause 1 1/6/2023 12:37:19 PM
21 CRISPR therapy NTLA-2001 demonstrates durable responses in rare heart disease GN jerrykrause 1 11/12/2022 8:28:34 PM
20 Intellia Therapeutics Announces Positive Interim Clinical Data for its Second Systemi GN jerrykrause 2 9/17/2022 10:51:02 AM
19 Intellia offers first look at CRISPR drug for rare swelling disorder GN jerrykrause 2 9/17/2022 10:49:59 AM
18 Intellia Investors Are Dumping Stock on News of Crispr Gene-Editing Success GN jerrykrause 2 9/16/2022 8:14:04 PM
17 Crispr Gene-Editing Drugs Show Promise in Preliminary Study GN jerrykrause 1 9/16/2022 12:03:08 PM
16 Intellia Therapeutics Receives U.S. FDA Orphan Drug Designation for NTLA-5001 for the Treatment of Acute Myeloid Leukemia GN jerrykrause 1 3/10/2022 7:41:00 PM
15 Intellia's CRISPR-engineered cell therapy secures FDA orphan drug status after AML trial launch GN jerrykrause 1 3/10/2022 7:38:58 PM
Previous 14 Messages Top of Message List Post Message Go to Msg #  




Financial Market Data provided by
.
Loading...